placebo-controlled [resa]
Trial [resa]
effects [qlco]
tibolone [phsu, strd]
Blood Pressure [orgf]
Lipids [lipd]
hypertensive [fndg]
Women [popg]
effects [qlco]
Hormone replacement therapy [topp]
hypertensive [fndg]
Women [popg]
controversies [socb]
placebo-controlled [resa]
Trial [resa]
Assessed [acty]
tibolone 2.5 MG [clnd]
Blood Pressure [orgf]
Fasting [fndg]
Plasma lipids [lbpr]
hypertensive [fndg]
postmenopausal [tmco]
Women [popg]
months [tmco]
Randomization [resa]
tibolone [phsu, strd]
Primary Endpoint [irda]
Mean blood pressure [fndg]
Office [mnob]
months [tmco]
Systolic blood pressure [clna]
Diastolic blood pressure [clna]
tibolone [phsu, strd]
placebo [topp]
Not significant [fndg]
Statistically [ocdi]
Triglycerides [bacs, lipd]
Decreased [qnco]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
P NOS [aapp, imft]
tibolone [phsu, strd]
placebo [topp]
Observed [ftcn]
Total Cholesterol [lbpr]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Lipoprotein (a) [aapp, bacs]
fibrinogen levels [lbpr]
Reduced [qlco]
tibolone [phsu, strd]
Compared [acty]
P NOS [aapp, imft]
placebo [topp]
Study [mnob]
Suggest [idcn]
tibolone [phsu, strd]
Blood Pressure [orgf]
Women [popg]
Hypertension [dsyn]
contrasting [diap]
effects [qlco]
Biochemical [ftcn]
risk factors [qnco]
Required [ftcn]
tibolone [phsu, strd]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
